This podcast reviews the newly revised ASHP Guidelines on Emergency Medicine Pharmacist Services. Originally released in 2011, a group of emergency medicine clinical pharmacy specialist content experts conducted a literature search for updated supporting evidence and updated the recommendations to establish reasonable goals on attainable best practices.
SPEAKERS
Vicki Basalyga, Pharm.D., BCPS, BCPPS, is the Director for the Section of Clinical Specialists and Scientists. In this role Vicki serves as an information resource and provides guidance to ASHP members regarding science and scientific developments affecting pharmacy practice in health systems. She serves as secretary to the Section executive committee and coordinates activities to accomplish the objectives established by the Section. Additionally, Vicki has assumed the position of Council Secretary for the ASHP's Council on Therapeutics.
Vicki received her Doctor of Pharmacy from Duquesne University and completed an ASHP accredited PGY1 at Children’s National Medical Center in Washington, DC. Vicki is also a Board Certified Pharmacotherapy Specialist and a Board Certified Pediatric Pharmacotherapy Specialist.
Prior to her current position at ASHP, Vicki practiced as critical care pharmacist in both the Cardiac Intensive Care Unit and the Pediatric Intensive Care Unit at Children’s National Medical Center in Washington, DC. Other activities Vicki performed included drafting policies and procedures, co-chairing the Antimicrobial Stewardship Program, creating and drafting order sets for CPOE conversion and precepting residents and students.
Dr. Andrew Smith is an emergency medicine pharmacist specialist at Scripps Mercy San Diego. Dr. Smith has spoken both locally and nationally on a variety of topics, including opioid use disorder and managing cannabis dependent patients during inpatient stays. He actively serves on ASHP’s Emergency Medicine Section Advisory Group as the Chair of the podcast committee, and was recently elected to serve on the San Diego Society of Health System Pharmacists Board of Directors and House of Delegates
Dr. Bryan Hayes is an Attending Pharmacist of Emergency Medicine and Clinical Toxicology at Massachusetts General Hospital and an Assistant Professor of EM at Harvard Medical School. He is the Program Director for the MGH PGY-2 EM Pharmacy Residency. Dr. Hayes served on the ASHP Emergency Medicine Section Advisory Group from 2013-2019 (Chair 2017-2018).
Dr. Giles Slocum is a clinical pharmacy specialist in emergency medicine at Rush University Medical Center in Chicago, Illinois. Giles received his BS in Biology from Iowa State University and his Pharm.D. from the University of Iowa. After graduation Giles completed a PGY1 at SwedishAmerican Hospital in Rockford, Illinois and a PGY2 in Emergency Medicine at University of Rochester Medical Center in Rochester, New York. His interest areas include emergency medicine, hemophilia management, and toxicology.
Dr. Melinda Ortmann has been in active clinical practice for over ten years. After working for several years as a Clinical Pharmacist in Pediatric Intensive Care she transitioned to a clinical role in Emergency Medicine, and currently practices as a Clinical Pharmacy Specialist in Emergency Medicine at The Johns Hopkins Hospital. She is a Board Certified Pharmacotherapy Specialist and serves as a preceptor for both PGY-1 and PGY-2 residency training programs, program coordinator for the PGY-2 Emergency Medicine Pharmacy Residency Program, as well as an educator for Emergency Medicine medical residents at JHH. In both clinical positions, Dr. Ortmann has been responsible for management of patients in acute resuscitation and critical care settings, as well as those with internal medicine and ambulatory care needs.